#sackler-family

#sackler-family

The Sackler family is often viewed as a key real-life villain due to their role in the opioid crisis.

The Sackler family, former owners of Purdue Pharma, negotiated immunity from future civil lawsuits without declaring bankruptcy.

The Department of Justice argues that this immunity deal goes too far and should require congressional authorization.

US Supreme Court blocked Purdue Pharma's bankruptcy settlement shielding Sackler family from lawsuits over opioid epidemic.

The U.S. Supreme Court rejected a nationwide settlement with Purdue Pharma, blocking the shield for the Sackler family and billions to combat opioids.

The Supreme Court rejected a nationwide settlement with Purdue Pharma, impacting the Sackler family and victims of the opioid epidemic.

The Supreme Court rejected a nationwide settlement with Purdue Pharma, impacting the Sackler family and victims of the opioid epidemic.

Law firm leaders are less optimistic about the future, despite positive growth and lower inflation rates.

The Supreme Court is examining the legality of a shield protecting the Sackler family from opioid settlements.

The Supreme Court heard arguments over a bankruptcy deal for Purdue Pharma that would shield the Sackler family from additional opioid-related lawsuits.

The court's decision could have significant consequences for other cases that use the bankruptcy system to settle mass injury claims.

The Supreme Court justices are divided on the bankruptcy settlement for Purdue Pharma that would shield the Sackler family from civil lawsuits related to the opioid epidemic.

The case raises questions about the practical effect of unraveling the agreement and the broader concerns over the Sacklers' liability in the opioid crisis.

The Supreme Court is considering a challenge to a deal that would compensate victims of the opioid epidemic while protecting the Sackler family from lawsuits.

The justices are grappling with the dilemma of prioritizing money or principle in deciding the fate of the multi-billion dollar Purdue Pharma bankruptcy deal.

The Supreme Court is hearing arguments on whether a settlement involving Purdue Pharma and the Sackler family is a violation of federal law, with potential implications for other organizations using bankruptcy court to resolve mass injury claims.

The case revolves around whether a legal maneuver in the settlement agreement can grant the Sackler family full immunity from civil lawsuits related to the opioid crisis.

Legal actions being prepared against the Sackler family for their role in the opioid crisis despite denied legal immunity.

The Supreme Court's decision impacts Purdue Pharma's bankruptcy plan, leading to uncertainty for addiction combat funds.